2021 France Molecular Diagnostics Market Assessment--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

   -  Cancer

 

   -  Paternity Testing/HLA Typing

 

   -  Forensic Testing

 

  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

Contains 1,125 pages and 58 tables This new 1,125-page report from LeadingMarketResearch.com contains 58 tables, and presents a comprehensive analysis of the French molecular diagnostics market, including:

  • Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Ten-year test volume and reagent sales forecasts for the following categories:

   -  Infectious Diseases

 

   -  Genetic Diseases

 

   -  Cancer

 

   -  Paternity Testing/HLA Typing

 

   -  Forensic Testing

 

  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

Contains 1,125 pages and 58 tables

I. Introduction
 II. Major Product Development Opportunities
 A. Instrumentation
 B. Reagent Kits and Test Systems/panels
 C. Computers, Software and Automation
 D. Auxiliary Products
 III. Design Criteria for Decentralized Testing Products
 IV. Alternative Market Penetration Strategies
 A. Internal Development
 B. Collaborative Arrangements
 C. University Contracts
 D. Distribution Strategies for Decentralized Testing
 Markets
 V. Potential Market Entry Barriers and Risks
 A. Market Maturity
 B. Cost Containment
 C. Competition
 D. Technological Edge and Limitations
 E. Patent Protection
 F. Regulatory Constraints
 G. Decentralized Testing Market Challenges
 VI. Market and Technology Review
 A. DNA Sequencing
 1. Introduction
 2. Sequencing Methods
 3. Autoradiography
 4. The Human Genome Project
 5. Sequencing Automation
 6. Image Scanners
 7. Fluorescent Detection
 8. Gene Profiling
 9. Gene Expression
 10. Polymorphism Screening
 11. Protein Interaction Networks
 B. DNA and RNA Probe Technologies
 1. Basic Principles
 2. Probe Preparation
 3. The DNA Probe Test
 4. Test Formats
 5. Labeling Techniques
 6. Amplification Methods
 C. Detection Technologies
 1. Radioactive Methods
 2. Non-Isotopic Methods
 D. Instrumentation
 Review of latest analyzers from Abbott, Beckman Coulter/Danaher,
  Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Hologic, Qiagen, Roche,
 †Siemens Healthineers, and others.
 E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
 F. Pharmacogenomics
 G. Major Applications
 1. Microbiology/Infectious Diseases
 a. Overview
 b. Major Infectious Diseases
 ° AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT,
 Western Blot, HTLV-I/II
 ° Adenovirus
 ° Aeromonas
 ° Anthrax/Bacillus Anthracis
 ° Arboviruses
 ° Babesiosis
 ° Bacillary Epithelioid Angiomatosis (BEA)
 and Other Bartonella (Rochalimaea)
 ° Blastocystis Hominis
 ° Brucella
 ° Campylobacter
 ° Candida
 ° Chagas Disease
 ° Chancroid
 ° Chlamydia
 ° Clostridium Difficile
 ° Coronaviruses
 ° Coxsackieviruses
 ° Creutzfeldt-Jakob’s Disease
 ° Cryptosporidium Parvum
 ° Cyclospora Cayetanensis
 ° Cytomegalovirus
 ° Ebola Virus
 ° E. Coli
 ° EchoVirus
 ° Encephalitis
 ° Enteroviruses
 ° Epstein-Barr Virus
 ° Giardia Lamblia
 ° Gonorrhea
 ° Granuloma Inguinale
 ° Hantavirus
 ° Helicobacter Pylori
 ° Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
 Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
 HBe Ag, ALT/SGPT
 ° Herpes Simplex Virus
 ° Human Herpes Virus-6 (HHV-6)
 ° Influenza Viruses
 ° Legionella
 ° Lyme Disease
 ° Lymphogranuloma Venereum (LGV)
 ° Malaria
 ° Measles (Rubeola)
 ° Meningitis
 ° Microsporidium
 ° Mononucleosis
 ° Mumps
 ° Mycoplasma
 ° Papillomaviruses
 ° Parvovirus B19
 ° Pneumonia
 ° Polyomaviruses
 ° Pseudomonas Aeruginosa
 ° Rabies
 ° Respiratory Syncytial Virus (RSV)
 ° Rhinoviruses
 ° Rotavirus
 ° Rubella
 ° Salmonellosis
 ° Septicemia
 ° Shigellosis
 ° Staphylococcus Aureus
 ° Streptococci
 ° Syphilis
 ° Toxoplasmosis
 ° Trichomonas Vaginalis
 ° Tuberculosis
 ° Vibrio
 ° West Nile Virus
 ° Yersina
 2. Cancer Testing
 a. Overview
 b. Major Cancer Types
 * Prostate
 * Lung
 * Colon and Rectum
 * Breast
 * Skin
 * Uterine
 * Leukemia
 * Oral
 c. Oncogenes
 The report provides review of both current and emerging oncogenes, including:
 O Abl/abl-bcr
 O AIB1
 O BCL-2
 O BRCA1
 O CD44
 O C-fos
 O C-myb
 O C-myc
 O CYP17
 O Erb-B
 O HPC1
 O N-myc
 O P40
 O P51
 O P53
 O PIK3CA
 O PTI-1
 O Ras
 O Reg
 O Sis
 O Src
 3. Genetic Diseases
 a. Overview
 b. Nucleic Acid Amplification
 c. Chromosome Imaging
 d. Genomics Technologies
 e. Proteomics Technologies
 f. Current Pharmacogenomic Tests
 g. Future Pharmacogenomic Testing
 h. Major Diseases
 * Achondroplasia
 * Autosomal Dominant Polycystic Kidney
 Disease
 * Cancer
 * Cosmetogenomics
 * Cystic Fibrosis
 * Downs Syndrome
 * Duchenne and Becker Muscular Dystrophy
 * Factor V (Leiden)
 * Factor IX Deficiency
 * Fragile X Syndrome
 * Heart Disease
 * Hemochomatosis
 * Hemophilia
 * Huntingtons Disease
 * Maternal-Fetal Incompatibility
 * Multiple Endocrine Neoplasia
 * Phenylketonuria (PKU)
 * Polycystic Kidney Disease (PKD)
 * Prenatal Screening
 * Retinitis Pigmentosa
 * Retinoblastoma
 * Sickle Cell Anemia
 * Spinal Muscular Atrophy
 * Vitamin B12 Metabolism
 i. Social Issues and Concerns
 4. Forensic Testing
 a. Overview
 b. Multilocus and Single Locus Probes
 c. The FBI
 d. DNA Profile Data Banks
 e. Judicial Implementation
 f. Major Crime Categories
 g. Factors Contributing to the DNA Probe
 Market Expansion
 h. Wildlife Forensics
 5. Paternity Testing/HLA Typing
 6. Other Applications
 a. Disease Susceptibility Testing
 b. Cardiovascular Diseases
 c. Diabetes
 d. Alzheimers Disease
 e. Periodontal Disease
 f. Plasma Purification
 g. Organ Transplantation
 h. W ater Contamination
 i. Other
 H. Competing/Complementing Technologies
 1. Monoclonal Antibodies/Immunoassays
 2. RNA Probes
 3. Two-Dimensional Electrophoresis
 4. Flow Cytometry
 VII. Molecular Diagnostics Market
 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Test Volume and Sales Forecasts,
 Major Supplier Sales and Market Shares
 VIII. Competitive Assessments
 The report provides strategic assessments of over 40 leading molecular diagnostics
 market players and start-up companies with innovative technologies and products,
 including:
 Abbott, Agilent Technologies, Beckman Coulter/Danaher, Becton Dickinson,
 bioMerieux, Bio-Rad, Cepheid, DiaSorin, Eiken Chemical, Enzo, Fujirebio, Grifols,
 Hologic, Illumina, LabCorp/Sequenom, Leica Biosystems, Myriad Genetics, OrthoClinical Diagnostics, Qiagen, Quest Diagnostics, Quidel, Roche, Shimadzu,
 Siemens Healthineers, Sierra Molecular, Takara Bio, Tecan Group, Thermo Fisher,
 Wako and others.
 Major Companies Developing or Marketing AIDS Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing Adenovirus
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Campylobacter
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Candida
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Chlamydia
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Cryptosporidium
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing CMV Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing EBV Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing Gonorrhea
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Helicobacter
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Hepatitis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Herpes
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Influenza
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Legionella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Lyme
 Disease Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Malaria
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Measles
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Meningitis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Mononucleosis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Mumps
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Mycoplasma
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Pneumonia
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing RSV
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Rotavirus
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Rubella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Salmonella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Septicemia
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Shigella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Streptococci
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Syphilis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Toxoplasmosis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Trichomonas
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Tuberculosis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Oncogenes Potential Application in Cancer Diagnosis
 Major Companies Developing or Marketing Cancer
 Molecular Diagnostic Tests
 Major Companies Developing or Marketing Molecular
 Diagnostic Tests For Genetic Diseases
 France
 Molecular Diagnostics Test Volume And Sales
 By Major Application
 France
 Laboratories Performing DNA Sequencing
 By Market Segment
 France
 Molecular Diagnostics Market
 Potential Laboratory Universe by Market Segment
 France
 Molecular Diagnostics Test Volume
 By Major Application
 France
 Major Infectious Disease Test Volume by Assay
 France
 Major Infectious Disease Test Volume by Method
 France
 Molecular Diagnostics Market
 By Major Application
 France
 Molecular Diagnostics Market
 Estimated Sales And Market Shares of Major Suppliers
 France
 Major Infectious Disease Diagnostics Market by Assay
 France
 AIDS Testing Market
 Estimated Sales by Major Supplier
 France
 Adenovirus Testing Market
 Estimated Sales by Major Supplier
 France
 Chlamydia/Gonorrhea Testing Market
 Estimated Sales by Major Supplier
 France
 CMV Testing Market
 Estimated Sales by Major Supplier
 France
 Hepatitis C Testing Market
 Estimated Sales by Major Supplier
 France
 HIV/Hepatitis Blood Screening NAT Market
 Reagent Sales by Major Supplier
 France
 Herpes Testing Market
 Estimated Sales by Major Supplier
 France
 Influenza Testing Market
 Estimated Sales by Major Supplier
 France
 Meningitis Testing Market
 Estimated Sales by Major Supplier
 France
 Mycoplasma Testing Market
 Estimated Sales by Major Supplier
 France
 RSV Testing Market
 Estimated Sales by Major Supplier
 France
 Shigella Testing Market
 Estimated Sales by Major Supplier 


List Of Tables

Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Tests For Genetic Diseases
France
Molecular Diagnostics Test Volume And Sales
By Major Application
France
Laboratories Performing DNA Sequencing
By Market Segment
France
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
France
Molecular Diagnostics Test Volume
By Major Application
France
Major Infectious Disease Test Volume by Assay
France
Major Infectious Disease Test Volume by Method
France
Molecular Diagnostics Market
By Major Application
France
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers
France
Major Infectious Disease Diagnostics Market by Assay
France
AIDS Testing Market
Estimated Sales by Major Supplier
France
Adenovirus Testing Market
Estimated Sales by Major Supplier
France
Chlamydia Testing Market
Estimated Sales by Major Supplier
France
CMV Testing Market
Estimated Sales by Major Supplier
France
Gonorrhea Testing Market
Estimated Sales by Major Supplier
France
Hepatitis Testing Market
Estimated Sales by Major Supplier
France
Hepatitis C Testing Market
Estimated Sales by Major Supplier
France
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier
France
Herpes Testing Market
Estimated Sales by Major Supplier
France
Influenza Testing Market
Estimated Sales by Major Supplier
France
Meningitis Testing Market
Estimated Sales by Major Supplier
France
Mycoplasma Testing Market
Estimated Sales by Major Supplier
France
RSV Testing Market
Estimated Sales by Major Supplier
France
Shigella Testing Market
Estimated Sales by Major Supplier


2021 Ecuador Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Ecuador Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 3500

USD 3500 View Report

2021 Dominican Republic Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Dominican Republic Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 3500

USD 3500 View Report

2021 France Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 France Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 4500

USD 4500 View Report

2021 France Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 France Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 3500

USD 3500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available